Skip to main content
Caplight Logo









novaxomx

novaxomx

Private
FrankfurtHealthcare & Life Scienceshttps://www.novaxomx.com/

Last Round

Joint Venture

Mar 21, 2022

Company Overview

novaxomx is a biotechnology company that develops biosurgical therapies for musculoskeletal diseases and tissue regeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

exosome technologytissue regenerationbone regenerationbiosurgical therapiesregenerative medicineexosome therapymusculoskeletal diseasesbiologicsorthopedicsspine surgerybone graft substitutesurgical biomaterialspre-clinical researchbiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

novaxomx Comparables

Compare novaxomx with similar companies based on industry and business-model similarity.

novaxomx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Theradaptive
79%
Cerapedics
68%
RevBio, Inc.
63%

novaxomx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Joint VentureMar 21, 2022

novaxomx Investors

Notable investors and investment history

novaxomx investors
InvestorRounds
Xlife Sciences AGJoint Venture

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Monthly visitors grew 155% MoM, from 118 to 301.

novaxomx Filings

Explore SEC and related filing metadata, where available.

novaxomx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about novaxomx's valuation, stock price, and market status.

Is novaxomx a public or private company?

novaxomx is a private company.

What is the current stock price of novaxomx?

novaxomx is a private company with no public stock price. No recent secondary market data is available.

How much is novaxomx worth (valuation)?

Valuation information for novaxomx is not publicly available.

Can I buy novaxomx stock?

novaxomx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was novaxomx's last funding round?

Funding round information for novaxomx is not publicly available.

Who are the main investors in novaxomx?

Investor information for novaxomx is not publicly disclosed.

Will novaxomx IPO soon?

No public IPO plans have been announced for novaxomx.

How can I track novaxomx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor novaxomx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrankfurt
Year Founded2022
Last FundingMar 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?